New Publication on "Targeted Social Marketing of PrEP and the Stigmatization of Black Sexual Minority Men" |
|
DC CFAR Pilot Award Recipient Dr. Sarah Calabrese (GW) with DC CFAR Co-Director Dr. Manya Magnus (GW), Cure SWG Co-lead Mr. Riko Boone (TAG), and SBS Core Co-Director Dr. Maria Cecilia Zea (GW) and colleagues published an article in the Journal of PLOS ONE in May 2023 entitled " Targeted social marketing of PrEP and the stigmatization of black sexual minority men".The authors conducted a mixed methods study to understand Black sexual minority men's response to target PrEP advertisements. This publication builds from Dr. Calabrese's DC CFAR Pilot project titled "Optimizing PrEP Social Marketing to Black MSM in DC to Raise Awareness and Uptake".
Please click here to read the article.
|
|
New Publication on Barriers and Facilitators to Culturally Responsive HIV and PrEP Screening |
Please click here to read the article.
|
|
DC CFAR Sexual and Gender Minorities Scientific Interest Group June 1 Meeting |
The DC CFAR Sexual and Gender Minorities (SGM) Scientific Interest Group (SIG) is pleased to announce its next important meeting which is open to all interested CFAR members. The SGM SIG is now led by Dr. David Huebner (GW) and Dr. Jonathon Rendina (WW) as the academic co-leads and Christian Morris (UHU) and SaVanna Wanzer (May Is? All About Trans) as the community co-leads. The SIGs are multi-disciplinary, multi-institutional groups co-led by DC CFAR investigators and community members. The goal of the Sexual and Gender Minorities SIG is to provide an interactive and thought-provoking forum to promote collaborations among researchers and community partners interested in HIV prevention, treatment, and care among sexual orientation and gender identity minorities.
The SGM SIG will be hosting a virtual panel discussion on the current landscape for Transgender and Nonbinary persons in DC on June 1st at 12:30 pm. The panel will be moderated by Dr. Kellan Baker (WW) and include esteemed panelists Sandy James, Kymberly Gordon (Damien Ministries), Alexa Rodriguez (TransLatinx DMV), and Tessa.
Please share this invite with others.
If you would like to participate in this meeting or join this group, please contact Ms. Allison O'Rourke.
|
|
|
HOLD THE DATE - DC CFAR Scientific Symposium, October 10 |
The DC CFAR is proud to announce the Return of the DC CFAR Scientific Symposium – 2023! The symposium will be held on Tuesday, October 10 from 9:30 am-3:30 pm in the GW Milken Institute School of Public Health Convening Center. This will be the first CFAR-wide event that we have held in person since the onset of the pandemic, and we are greatly looking forward to bringing the DC HIV community together once again for this exciting symposium.
We will soon begin inviting speakers and planning the logistics for the symposium, but we wanted to notify you now so that you can HOLD THIS DATE on your calendars. We are grateful for your continued support of and engagement with the DC CFAR!
|
|
Save the Date: DC CFAR Virtual Citywide Seminar on the District of Columbia Clinical Trials Unit |
Please join us for a virtual Citywide Seminar on Thursday, June 8 from 5:00-6:30 pm. The seminar will feature presentations focused on the District of Columbia Clinical Trials Unit (DC CTU) from Dr. Manya Magnus (DC CFAR Co-Director and DC CTU MPI), Ms. Melissa Turner (CPC Member and DC CTU Community Engagement Lead), Dr. Sarah Henn (Chief Health Officer at Whitman Walker and DC CTU MPI), and Dr. Marc Siegel (CPS Core Associate Director and DC CTU MPI).
Presentations will cover the history of the DC CTU, current clinical trials for HIV prevention and treatment, and ways to engage with NIH-funded cutting-edge clinical trials in DC.
|
|
|
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. |
|
Below you will find several resources of interest developed and gathered by DC CFAR partner institutions and community-based organizations. We encourage you to send information that may be of interest to our DC CFAR community to CFARinDC@gmail.com.
|
|
DC CFAR partner institutions and community-based organizations have developed numerous excellent COVID-19 resources. We've included a collection of these here, along with a number of other opportunities for your reference. We will continue to update these resources in the days ahead and we encourage you to send information that may be of interest to our DC CFAR community to CFARinDC@gmail.com.
|
|
DC CFAR Sexual and Gender Minorities Scientific Interest Group Meeting
June 1, 2023
June 3-7, 2023
Washington, DC
June 5-6, 2023
June 5, 2023
June 8, 2023
June 9, 2023
June 13, 2023
June 15, 2023
June 19, 2023
June 22, 2023
June 26, 2023
June 28-29, 2023
July 10-21, 2023
July 11, 2023
July 23-26, 2023
Brisbane, Australia
July 22, 2023
Brisbane, Australia
July 31-August 4, 2023
Boulder, Colorado
August 7-11, 2023
Bethesda, Maryland
August 15, 2023
August 20-23, 2024
For more DC CFAR events please see the calendar here.
|
|
FUNDING, TRAINING AND MENTORING OPPORTUNITIES
|
|
Join on July 10-11 a grant writing workshop hosted by the Department of Pharmaceutical Sciences, College of Pharmacy, Howard University. This free in-person workshop is for faculty, postdocs, and research development professionals interested in pursuing NIH funding for their research.
Avant-Garde and Avenir Awards
These NIDA HIV research programs award funds to investigators planning high-impact research projects focused on the prevention and treatment of HIV/AIDS among people who use drugs. Avant is for groundbreaking researchers at all levels of their careers and Avenir focuses on early-stage investigators. Applications period July 15-August 15, 2023.
The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR) and collaborators recently launched a Phase 1 trial that will evaluate safety, tolerability, and immunogenicity of varying doses of the Army’s novel ALFQ adjuvant in a candidate HIV vaccine to optimize adjuvant dosage. For more information including eligibility, please see the flyer here.
The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a funding opportunity to support substance use and HIV prevention services for racial and ethnic minority populations at high-risk for substance use disorders (SUDs) and HIV infection. Applications are due June 20.
|
|
NIH FUNDING OPPORTUNITIES
|
|
Funding Opportunity Number: PAR-23-190
Posting Date: May 10, 2023
Closing Date: December 20, 2023
Funding Opportunity Number: PAR-23-191
Posting Date: May 10, 2023
Closing Date: December 8, 2023
Funding Opportunity Number: PAR-23-169
Posting Date: April 21, 2023
Closing Date: August 2, 2023
Funding Opportunity Number: RFA-AI-23-026
Posting Date: April 21, 2023
Closing Date: August 2, 2023
Funding Opportunity Number: RFA-AI-23-023
Posting Date: April 14, 2023
Closing Date: August 2, 2023
Funding Opportunity Number: RFA-DE-24-002
Posting Date: April 7, 2023
Closing Date: July 24, 2023
Funding Opportunity Number: RFA-DE-24-001
Posting Date: April 7, 2023
Closing Date: July 24, 2023
Click here for additional funding opportunities available from the National Institutes of Health.
|
|
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
|
|
|
|
|
|
|
